ArticleBMC microbiology2026
Lineage-specific type 1 fimbriae in hypervirulent ST23 Klebsiella pneumoniae target α3β1 integrin to promote intestinal epithelial invasion.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Hypervirulent Klebsiella pneumoniae (hvKp), particularly sequence type 23 (ST23), is a predominant global cause of pyogenic liver abscesses. While ST23 hvKp is strongly associated with this invasive pathology, the molecular basis for its enhanced gut translocation potential, a critical prerequisite for hematogenous dissemination to the liver, remains unclear. Phylogenetic analysis of type 1 fimbrial gene clusters revealed that ST23 isolates uniquely encode a distinct combination of fimbrial subunits. Using engineered strains, we demonstrated that ST23-derived type 1 fimbriae, but not those from the ST11 lineage of classical K. pneumoniae, specifically bind to host enterocyte α3β1 integrins. This specific interaction conferred superior invasion capacity across intestinal epithelial barriers to ST23 hvKp compared to strains expressing ST11 fimbriae (P < 0.05). Thus, ST23 hvKp exploits lineage-specific type 1 fimbriae to target α3β1 integrin, driving efficient gut epithelial invasion-a pivotal initial step in systemic dissemination leading to liver abscess formation. This work identifies a dedicated molecular invasion system intrinsic to ST23 hvKp, mechanistically explaining its enhanced invasive capacity and strong clinical association with pyogenic liver abscesses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.